Cargando…

Serum biomarkers differentiating Kawasaki disease from febrile infections: A pilot case-control study

Although some serum biomarkers are elevated in both Kawasaki disease (KD) and infections, these conditions have not been compared by individual or combined biomarkers. The aim of this study, undertaken between January 2016 and May 2018 in a large teaching hospital, was to compare the serum concentra...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Asad Aziz, George, Junu Vazhappully, Al Hamad, Sania Mazin Shareef, Jayaraj, Richard L., Narchi, Hassib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715059/
https://www.ncbi.nlm.nih.gov/pubmed/33304152
http://dx.doi.org/10.1016/j.sjbs.2020.09.034
_version_ 1783618865636311040
author Khan, Asad Aziz
George, Junu Vazhappully
Al Hamad, Sania Mazin Shareef
Jayaraj, Richard L.
Narchi, Hassib
author_facet Khan, Asad Aziz
George, Junu Vazhappully
Al Hamad, Sania Mazin Shareef
Jayaraj, Richard L.
Narchi, Hassib
author_sort Khan, Asad Aziz
collection PubMed
description Although some serum biomarkers are elevated in both Kawasaki disease (KD) and infections, these conditions have not been compared by individual or combined biomarkers. The aim of this study, undertaken between January 2016 and May 2018 in a large teaching hospital, was to compare the serum concentration of cytokines, metalloproteinases (MMP) and heat shock protein (HSP) between cases defined as children with Kawasaki disease (KD) and those with febrile infections (controls). Serum concentrations of tumour necrosis factor-alpha (TNF-alpha), interleukins (IL 1beta, 6, and 8), heat shock proteins (HSP 60 and 70) and matrix metalloproteinase (MMP 9) were measured on admission in 17 children under six years of age with a temperature >38.5 °C for ≥five days, and compared between the two groups. The median age was 25 months and the median duration of fever eight days. Seven children were diagnosed with KD and ten had a febrile infection. Only the serum concentrations of IL-6 and TNF-alpha were significantly higher in the former than in the latter group (P = 0.01 and 0.04 respectively). To differentiate between the two groups with the best sensitivity and specificity, the optimal cut-off value for IL-6 was 12.6 pg/mL, and for TNF-alpha 47.9 pg/mL. Their combined increase, however, outperformed their individual concentrations. The characteristic diagnostic “signature” of the combined elevation of IL-6 and TNF-alpha serum levels has the potential, in febrile children, to differentiate early KD from febrile infections, allowing the institution of appropriate therapy.
format Online
Article
Text
id pubmed-7715059
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-77150592020-12-09 Serum biomarkers differentiating Kawasaki disease from febrile infections: A pilot case-control study Khan, Asad Aziz George, Junu Vazhappully Al Hamad, Sania Mazin Shareef Jayaraj, Richard L. Narchi, Hassib Saudi J Biol Sci Original Article Although some serum biomarkers are elevated in both Kawasaki disease (KD) and infections, these conditions have not been compared by individual or combined biomarkers. The aim of this study, undertaken between January 2016 and May 2018 in a large teaching hospital, was to compare the serum concentration of cytokines, metalloproteinases (MMP) and heat shock protein (HSP) between cases defined as children with Kawasaki disease (KD) and those with febrile infections (controls). Serum concentrations of tumour necrosis factor-alpha (TNF-alpha), interleukins (IL 1beta, 6, and 8), heat shock proteins (HSP 60 and 70) and matrix metalloproteinase (MMP 9) were measured on admission in 17 children under six years of age with a temperature >38.5 °C for ≥five days, and compared between the two groups. The median age was 25 months and the median duration of fever eight days. Seven children were diagnosed with KD and ten had a febrile infection. Only the serum concentrations of IL-6 and TNF-alpha were significantly higher in the former than in the latter group (P = 0.01 and 0.04 respectively). To differentiate between the two groups with the best sensitivity and specificity, the optimal cut-off value for IL-6 was 12.6 pg/mL, and for TNF-alpha 47.9 pg/mL. Their combined increase, however, outperformed their individual concentrations. The characteristic diagnostic “signature” of the combined elevation of IL-6 and TNF-alpha serum levels has the potential, in febrile children, to differentiate early KD from febrile infections, allowing the institution of appropriate therapy. Elsevier 2020-12 2020-09-23 /pmc/articles/PMC7715059/ /pubmed/33304152 http://dx.doi.org/10.1016/j.sjbs.2020.09.034 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Khan, Asad Aziz
George, Junu Vazhappully
Al Hamad, Sania Mazin Shareef
Jayaraj, Richard L.
Narchi, Hassib
Serum biomarkers differentiating Kawasaki disease from febrile infections: A pilot case-control study
title Serum biomarkers differentiating Kawasaki disease from febrile infections: A pilot case-control study
title_full Serum biomarkers differentiating Kawasaki disease from febrile infections: A pilot case-control study
title_fullStr Serum biomarkers differentiating Kawasaki disease from febrile infections: A pilot case-control study
title_full_unstemmed Serum biomarkers differentiating Kawasaki disease from febrile infections: A pilot case-control study
title_short Serum biomarkers differentiating Kawasaki disease from febrile infections: A pilot case-control study
title_sort serum biomarkers differentiating kawasaki disease from febrile infections: a pilot case-control study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715059/
https://www.ncbi.nlm.nih.gov/pubmed/33304152
http://dx.doi.org/10.1016/j.sjbs.2020.09.034
work_keys_str_mv AT khanasadaziz serumbiomarkersdifferentiatingkawasakidiseasefromfebrileinfectionsapilotcasecontrolstudy
AT georgejunuvazhappully serumbiomarkersdifferentiatingkawasakidiseasefromfebrileinfectionsapilotcasecontrolstudy
AT alhamadsaniamazinshareef serumbiomarkersdifferentiatingkawasakidiseasefromfebrileinfectionsapilotcasecontrolstudy
AT jayarajrichardl serumbiomarkersdifferentiatingkawasakidiseasefromfebrileinfectionsapilotcasecontrolstudy
AT narchihassib serumbiomarkersdifferentiatingkawasakidiseasefromfebrileinfectionsapilotcasecontrolstudy